Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects - Haschke, Manuel; Schuster, Manfred; Poglitsch, Marko; Loibner, Hans; Salzberg, Marc; Bruggisser, Marcel; Penninger, Joseph; Krähenbühl, Stephan (Clinical pharmacokinetics, 2013)
Keywords: Angiotensin I - blood; Angiotensin II - blood; Angiotensin-Converting Enzyme 2; Biological and medical sciences; Double-Blind Method; Female; General pharmacology; Humans; Internal Medicine; Male; Medical sciences; Medicine; Medicine & Public Health; Original Research Article; Peptide Fragments - blood; Peptidyl-Dipeptidase A - administration & dosage; Peptidyl-Dipeptidase A - pharmacokinetics; Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions; Pharmacology. Drug treatments; Pharmacology/Toxicology; Pharmacotherapy; Recombinant Proteins - administration & dosage; Recombinant Proteins - pharmacokinetics; ACE2 Knockout Mouse; Study Drug Administration; Endogenous Peptide Signal; Good Manufacture Practice Guideline; Healthy Human Subject; Human; Pharmacokinetic pharmacodynamic relationship; Recombinant protein; Healthy subject